Skip to main content

Table 3 CMR in COVID-related myocarditis research priorities

From: Utilization of cardiovascular magnetic resonance (CMR) imaging for resumption of athletic activities following COVID-19 infection: an expert consensus document on behalf of the American Heart Association Council on Cardiovascular Radiology and Intervention (CVRI) Leadership and endorsed by the Society for Cardiovascular Magnetic Resonance (SCMR)

Outcomes

Imaging—Follow-up CMR imaging in those with possible or probable myocarditis by baseline imaging

Clinical—Arrhythmia and adverse clinical outcomes in those possible or probable myocarditis by baseline imaging

Technical

Standardization of pulse sequences, inter-observer variability, and quantification schemes

Large, normative datasets of CMR in the healthy athlete by activity (power vs endurance, for example) and age

Cost effectiveness

Downstream costs of application in different utilization scenarios

Resource utilization and impact on CMR availability